EINPresswire/ -- According to DataM Intelligence, the RNAi Therapeutics Market will grow from USD 2.60 billion in 2024 to USD 8.80 billion by 2033, expanding at a robust CAGR of 14.6% between 2025 and ...
Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...
Introducing LLibra OS, a next-generation AI platform that accelerates discovery and evaluation of differentiated gene targets and siRNA design. LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Tangram ...
Discover the top biotech deals of September 2025, as four billion-dollar acquisitions took place and several licensing deals ...
Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of ...
In a study published in Nature Communications, a research team demonstrates the all-electrical control of quantum ...
"The results consistently show that in fields where resistance to Bt has evolved, the combination of Bt and RNA interference provides less protection from rootworm damage," said Bruce Tabashnik, lead ...
Corn rootworms, pests responsible for billions of dollars in yearly crop losses, are evolving resistance that weakens even the latest biotechnology controls, according to a new study published in the ...
The ISC Class 12 Half-Yearly Biology Exam 2025 marks a pivotal moment in your academic journey, setting the stage for your final board examinations. To navigate this crucial phase effectively, a ...
The new biotech is developing an antibody-oligo conjugate platform that uses "brain shuttles" to deliver drugs across the blood-brain barrier.